clinical trials

News

Disappointment as Novo's oral GLP-1 fails in Alzheimer's

GLP-1 agonists have been shown to be beneficial in a lengthening list of diseases, but it seems Alzheimer's disease may not be among them.

News

An older man holds his head in pain while lights flash

Stroke data breathes life back into Bayer's asundexian

Prospects for Bayer's oral Factor XIa inhibitor asundexian have improved markedly after a phase 3 trial in secondary stroke prevention.

News

J&J abandons Alzheimer's antibody in setback for tau

Hopes that anti-tau drugs could emerge as treatments for Alzheimer's have been dented by the failure of a phase 2b trial of J&J's posdinemab.

News

Neuralink rival Paradromics cleared to start speech trial

Brain computer interface developer Paradromics has been cleared to start a US clinical trial of its Connexus implant for speech restoration.

News

Agios shares slump on sickle cell disease data

Shares in Agios lost nearly half their value after it posted mixed clinical results from a phase 3 trial of its sickle cell disease therapy mitapivat.

R&D

a scientist in the lab holds a white mouse model in their gloved hands

Beyond animal testing: How human data trials are reshaping d...

Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.

Disappointment as Novo's oral GLP-1 fails in Alzheimer's

Stroke data breathes life back into Bayer's asundexian

J&J abandons Alzheimer's antibody in setback for tau

Neuralink rival Paradromics cleared to start speech trial

Agios shares slump on sickle cell disease data

Beyond animal testing: How human data trials are reshaping d...

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

clinical trials

Editor's Picks